Clinical trial

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

NCT00911118

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-26

PhasePHASE1

Study timeline

Study start (actual)2009-05-26Date precision: day

Registry last updated2026-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Adenocarcinomaunresolved

Interventions

Hypofractionated, image-guided, intensity-modulated external beam radiationRADIATION

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Montefiore Medical Centercollaborator

Mapped research locations

New YorkNew York, United States1 The BronxNew York, United States1 CommackNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00911118 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.